Funded Tech Companies
Celea Therapeutics
Wondering who invested in Celea Therapeutics? Leaps by Bayer, PureTech Ventures and RA Capital Management invested in this biopharmaceutical company.
Company Overview
Company Name
Celea Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
6 Tide Street 400
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Celea Therapeutics is dedicated to advancing transformative treatments for people with serious respiratory diseases. Drawn from the Latin word for "sky," our name reflects our mission: to rise above the status quo and deliver therapies that change lives. Our lead program, deupirfenidone (LYT-100), is advancing into Phase 3 development with the potential to set a new standard of care for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/2/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sven Dethlefs
Company Investors
- Leaps by Bayer
- PureTech Ventures
- RA Capital Management
Browse more funded tech companies:
Celcuity | Celebal Technologies
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs